Grant Number:	5R01CA230352-05 Interpret this number
Primary Investigator:	Barocas, Daniel
Organization:	Vanderbilt University Medical Center
Project Title:	10-Year Comparative Effectiveness and Harms of Treatments for Prostate Cancer
Fiscal Year:	2023

Project Summary The available literature regarding comparative effectiveness and comparative harms of management options for localized prostate cancer is inadequate to power a shared decision-making process between patients and providers. The few randomized trials that exist are flawed in important ways, leaving enormous uncertainty about how best to manage newly diagnosed prostate cancer, and possible trade-offs between side-effects and efficacy of surgery, radiation and active surveillance. A well-executed long-term, population-based study that assesses real-world outcomes in a diverse cohort would add considerably to the literature and could overcome some of the limitations of earlier randomized clinical trials. The Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) cohort is a population-based cohort study of approximately 3000 men (over 25% non-white) with localized prostate cancer, accrued in 2011-12. Longitudinal patient-reported data have been collected out to 5 years, and a medical chart review was performed 12 months after diagnosis. This cohort provides an invaluable opportunity to study comparative long-term oncologic and quality of life outcomes. In addition, its diversity and breadth make in an ideal cohort in which to study the influence of patient characteristics, such as baseline disease risk stratum, race, age and comorbidity, on these downstream outcomes. The Specific Aims are to: 1. Compare the clinical outcomes of surgery, radiation and active surveillance (cancer outcomes and complications). 2. Compare patient-reported outcomes of these management options with respect to disease-specific and general quality of life outcomes, financial toxicity, and qualitative outcomes 3. Explore the influence of baseline patient characteristics on the oncologic and quality of life outcomes. In order to accomplish these Aims, we will perform a patient survey and medical chart review 10 years after diagnosis, and we will perform structured qualitative research interviews with a sub-set of patients. The proposed study draws on the experience of the CEASAR investigators who have collaborated successfully since 2009 on the planning and execution of several rounds of data collection, analysis and publication. The results of this study will be utilized to inform the shared decision-making process, in order to improve concordance between treatment decisions and patient preferences and priorities.




Functional Outcomes After Localized Prostate Cancer Treatment.
Authors: Al Hussein Al Awamlh B. , Wallis C.J.D. , Penson D.F. , Huang L.C. , Zhao Z. , Conwill R. , Talwar R. , Morgans A.K. , Goodman M. , Hamilton A.S. , et al. .
Source: Jama, 2024-01-23 00:00:00.0; 331(4), p. 302-317.
PMID: 38261043
Related Citations

The lived experience of prostate cancer: 10-year survivor perspectives following contemporary treatment of localized prostate cancer.
Authors: Al Hussein Al Awamlh B. , Wallis C.J.D. , Diehl C. , Barocas D.A. , Beskow L.M. .
Source: Journal Of Cancer Survivorship : Research And Practice, 2023-05-12 00:00:00.0; , .
EPub date: 2023-05-12 00:00:00.0.
PMID: 37171717
Related Citations

Association between body mass index and localized prostate cancer management and disease-specific quality of life.
Authors: Samora N.L. , Wallis C.J.D. , Huang L.C. , Tallman J.E. , Zhao Z. , Hoffman K. , Morgans A. , Cooperberg M. , Goodman M. , Greenfield S. , et al. .
Source: Bjui Compass, 2023 Mar; 4(2), p. 223-233.
EPub date: 2022-11-02 00:00:00.0.
PMID: 36816144
Related Citations

Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer.
Authors: Tallman J.E. , Wallis C.J.D. , Zhao Z. , Huang L.C. , Penson D.F. , Koyama T. , Goodman M. , Hamilton A.S. , Wu X.C. , Paddock L.E. , et al. .
Source: Prostate Cancer And Prostatic Diseases, 2022-12-08 00:00:00.0; , .
EPub date: 2022-12-08 00:00:00.0.
PMID: 36482081
Related Citations

Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study.
Authors: De B. , Pasalic D. , Barocas D.A. , Wallis C.J.D. , Huang L.C. , Zhao Z. , Koyama T. , Tang C. , Goodman M. , Hamilton A.S. , et al. .
Source: The Journal Of Urology, 2022 12; 208(6), p. 1226-1239.
EPub date: 2022-08-25 00:00:00.0.
PMID: 36006050
Related Citations

The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate Cancer.
Authors: Joyce D.D. , Wallis C.J.D. , Huang L.C. , Hoffman K.E. , Zhao Z. , Koyama T. , Goodman M. , Hamilton A.S. , Wu X.C. , Paddock L.E. , et al. .
Source: Jnci Cancer Spectrum, 2022-11-01 00:00:00.0; 6(6), .
PMID: 36255249
Related Citations

Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes.
Authors: Luckenbaugh A.N. , Wallis C.J.D. , Huang L.C. , Wittmann D. , Klaassen Z. , Zhao Z. , Koyama T. , Laviana A.A. , Conwill R. , Goodman M. , et al. .
Source: The Journal Of Urology, 2022 May; 207(5), p. 1029-1037.
EPub date: 2022-03-03 00:00:00.0.
PMID: 34978488
Related Citations

Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer.
Authors: Tallman J.E. , Wallis C.J.D. , Huang L.C. , Zhao Z. , Penson D.F. , Koyama T. , Conwill R. , Goodman M. , Hamilton A.S. , Wu X.C. , et al. .
Source: Prostate Cancer And Prostatic Diseases, 2022-02-25 00:00:00.0; , .
EPub date: 2022-02-25 00:00:00.0.
PMID: 35217831
Related Citations

Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort.
Authors: Wallis C.J.D. , Huang L.C. , Zhao Z. , Penson D.F. , Koyama T. , Conwill R. , Tallman J.E. , Goodman M. , Hamilton A.S. , Wu X.C. , et al. .
Source: Urologic Oncology, 2022 02; 40(2), p. 56.e1-56.e8.
EPub date: 2021-06-19 00:00:00.0.
PMID: 34154899
Related Citations

Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.
Authors: Wallis C.J.D. , Zhao Z. , Huang L.C. , Penson D.F. , Koyama T. , Kaplan S.H. , Greenfield S. , Luckenbaugh A.N. , Klaassen Z. , Conwill R. , et al. .
Source: Jama Oncology, 2022-01-01 00:00:00.0; 8(1), p. 50-59.
PMID: 34792527
Related Citations

Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.
Authors: Laviana A.A. , Zhao Z. , Huang L.C. , Koyama T. , Conwill R. , Hoffman K. , Goodman M. , Hamilton A.S. , Wu X.C. , Paddock L.E. , et al. .
Source: European Urology, 2020 Aug; 78(2), p. 248-255.
EPub date: 2020-02-22 00:00:00.0.
PMID: 32098731
Related Citations

Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?
Authors: Laviana A.A. , Hernandez A. , Huang L.C. , Zhao Z. , Koyama T. , Conwill R. , Hoffman K. , Feurer I.D. , Goodman M. , Hamilton A.S. , et al. .
Source: The Journal Of Urology, 2019 12; 202(6), p. 1150-1158.
EPub date: 2019-06-19 00:00:00.0.
PMID: 31216252
Related Citations